FDA Watch: FDA Moves Slowly on AI-Driven Lab Devices
The agency has approved fewer than 10 tests in the past three years, but a new pipeline of AI-powered products is expected to emerge soon
The agency has approved fewer than 10 tests in the past three years, but a new pipeline of AI-powered products is expected to emerge soon
Meant to be temporary, remote regulatory assessments proved so successful that the agency will not only continue, but expand their use.
Now that the finishing touches have been put on LDT-related legislation, what is the likelihood that it will pass?
Senate committee members propose a modified version of legislation allowing the FDA to continue to regulate LDTs on a risk-tiered basis.
InspectIR COVID-19 device detects the virus from breath samples in less than three minutes, offering a new screening option.
The FDA has plans to ensure COVID-19 test makers won’t be left high and dry when the public health emergency ends.
The House Energy and Commerce Committee is considering a pair of rival bills, one Democratic and one Republican, to reform the AA process.